Stents Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Stents Market
Stents Market: By Product (Coronary, Peripheral, Stent-Related Implants, Biliary stents, Carotid stents, Neurovascular stents); By Material (Metallic, Polymeric, Natural) & By Region (Europe, Asia-Pacific, North America, RoW)-Forecast (2018-2023)
Report Code : HCR 0693
Updated Date: 24 July, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Stents Market – Overview
2. Executive Summary 
3. Stents Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Stents Market– Forces
   4.1. Drivers
      4.1.1. Increasing population of old age citizens and people with cardiac disorders
      4.1.2. Technological advancement in healthcare
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Stents Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Stents Market, By Product
   6.1. Coronary Stents
   6.2. Peripheral Stents
   6.3. Stent-Related Implants
   6.4. Biliary Stents
   6.5. Carotid Stents
   6.6. Neurovascular Stents 
7. Stents Market, By Material
   7.1. Metallic
   7.2. Polymeric
   7.3. Natural
8. Stents Market- By Geography
   8.1.  North America 
      8.1.1. U.S.  
      8.1.2. Canada 
      8.1.3. Mexico 
   8.2. South America 
      8.2.1. Brazil 
      8.2.2. Venezuela
      8.2.3. Argentina
      8.2.4. Ecuador
      8.2.5. Peru
      8.2.6. Colombia 
      8.2.7. Costa Rica
   8.3. Europe 
      8.3.1. U.K 
      8.3.2. Germany 
      8.3.3. Italy 
      8.3.4. France
      8.3.5. Netherlands
      8.3.6. Belgium
      8.3.7. Spain
      8.3.8. Denmark
   8.4. APAC
      8.4.1. China 
      8.4.2. Australia 
      8.4.3. South Korea
      8.4.4. India
      8.4.5. Taiwan
      8.4.6. Malaysia
      8.4.7. Hong Kong  
   8.5. Middle East& Africa 
   8.6. Russia
   8.7. Israel
   8.8. Other
9. Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs, Partnership
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. Abbott Laboratories
   10.2. B. Braun Melsungen AG
   10.3. Biotronik SE & Co. KG
   10.4. Boston Scientific Corporation
   10.5. C.R. Bard Inc.
   10.6. Elixir Medical Corporation
   10.7. Company 7
   10.8. Company 8
   10.9. Company 9
   10.10. Company 10
   10.11. Company 11
   10.12. Company 12
   10.13. Company 13
   10.14. Company 14
*More than 25 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Stent are small mesh tubes which is used to treat narrow or weak blood vessels or arteries that carry blood away from your heart to other parts of your body. The insertion of a stent helps in restoring the flow of blood or other fluids, depending on where it’s placed. Globally, increasing number of old age people and people with cardiac problems due to lifestyle changes are expected to remain the prime growth drivers for the stent market along with technological advancement in healthcare practices during the period of study. The count of 65 years or older population is expected to rise to 2 billion globally by 2050, according to a report published by WHO, it will lead to hike in demand for the stents in market

Geographically, North America dominated the stents market driven by a world class healthcare infrastructure with a technologically advanced practice, higher pool of old age & people with cardiac diseases, ease of access to medical facility, favorable government policies, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for stents market. Asia Pacific is projected to have the fastest growth, owing to a rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

Stents market is estimated at $10,761.2 million in 2017 and is expected to grow at a CAGR of more than 5.6%.

What are Stents ?
Stents are tiny expandable wire mesh tubes made up of metal or plastic mesh like materials that used to treat narrow or weak arteries and are placed into blood vessels, arteries or other hollow structures to open narrowed vessels and reduce the chances of chest pain or heart attack. The process for placement of stent into a body is known as stenting. A stent is placed in an artery as part of a procedure called percutaneous coronary intervention (PCI), also known as coronary angioplasty. Recovery from angioplasty and stenting is typically quick. After the catheter is removed, discharge from the hospital takes 12 to 24 hours. The insertion of a stent helps in restoring the flow of blood or other fluids, depending on its placement position. It is nowadays becoming widely accepted treatment for diseases like cardiac arrest which prove to be very crucial for healthy lifestyle.

Many patients are able to return to work within a few days to a week after a procedure. Vascular stent implantation is very common in modern hospitals it is used to improve cardiovascular system working and supplements the system. The implantation is assisted by use of modern instruments which involve displays such as X-ray, ECG, etc. for the stent. 

What are the major applications for Stents ?
Stents are implanted in a patient whose cardiac system functions improperly. They help in maintaining both arterial and venous patency in congenital heart disease. Stent implantation is used as a treatment for pulmonary arterial stenosis, coarctation, pulmonary and systemic venous obstruction, and obstructed homograft and conduits, in both the pediatric and adult populations. 

Coronary stents, specifically bare metal stents (BMS), are developed to provide an intracoronary scaffolding device to reduce elastic recoil and remodeling, thus reducing the rate of restenosis. The BMS is a small mesh tube which is pre-loaded on a catheter and that is guided forward from the aorta to the blocked area. At the lesion site it is expanded within the vessel. After expansion, the BMS serves as a scaffold to leave the artery open. Metal stents are typically made of implantable grade metals, such as: Stainless Steel (316LVM), Nickel Titanium (Nitinol), Titanium or Cobalt Chromium (CoCr) alloys (L605, MP35N).

Drug Eluting Stents are being developed and researched they almost eliminated the risk of the artery collapsing and have reduced the renarrowing of blood vessels by 10%. They have reduced the number of repeat procedures for diabetic people, who have a higher risk of their arteries getting narrow again.

Stents Market
 
Market Research and Market Trends of Stents Ecosystem
  • Increasing demand for minimal invasive surgeries globally will drive the market of vascular stents. In addition, ageing population will further drive the market growth of vascular stents. The count for people aged 65 years or above is expected to rise to touch 2 billion by 2050, according to a report published by WHO thereby increasing the geriatric population. It will induce  the demand of vascular stents hence will drive the market growth. In addition, an increase in adoption of vascular stents in emerging economies such as China, India and others, will create new opportunities for the this market.
  • Higher cost of research, evolution of preventive medicines, development, higher cost of stents, and availability of alternative therapies and treatments like coronary artery bypass surgery in low cost are the key restraints for the  stents market.
  • Governments are taking initiatives to cap the prices of lifesaving stents. With the developing biomedical sciences and innovations in technology these implantations are going to become simpler and cheaper and market is expected to keep steady growth.
  • In 2016, the FDA approved a new type of stent made of a special polymer that eventually dissolves into the body. This new stent releases a drug called everolimus, which limits the growth of scar tissue that can re-block the coronary artery.
  • According to WHO about 17.3 million people died from cardiovascular disease in 2008 and the number is expected to reach 23.3 million by 2030. This increase in number of patients suffering from cardiovascular disease across the world will supplement the demand of global stents in market.
  • Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing aging population, rise in consumer awareness, increasing healthcare expenditure favorable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the material, metal stents has the highest market share in the stents market.
  • Many new second- and third-generation stent designs are being developed, in clinical trials, or have been approved for use outside the U.S. These include:
  • One with a covering that delivers an anti-restenosis drug for months and then basically becomes a bare-metal stent
  • A version that is absorbed by the body and disappears after it has done its work
  • A stent that uses a coating to quickly create a thin, all-natural layer inside the artery

Who are the Major Players in Stents market?
The companies profiled in the report include  Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation

What is our report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years. 
  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market. 
List of Table s

Table 1: Stents MarketOverview 2017-2023
Table 2: Stents MarketLeader Analysis 2017-2018 (US$)
Table 3: Stents MarketProduct Analysis 2017-2018 (US$)
Table 4: Stents MarketEnd User Analysis 2017-2018 (US$)
Table 5: Stents MarketPatent Analysis 2013-2018* (US$)
Table 6: Stents MarketFinancial Analysis 2017-2018 (US$)
Table 7: Stents MarketDriver Analysis 2017-2018 (US$)
Table 8: Stents MarketChallenges Analysis 2017-2018 (US$)
Table 9: Stents MarketConstraint Analysis 2017-2018 (US$)
Table 10: Stents MarketSupplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Stents MarketBuyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Stents MarketThreat of Substitutes Analysis 2017-2018 (US$)
Table 13: Stents MarketThreat of New Entrants Analysis 2017-2018 (US$)
Table 14: Stents MarketDegree of Competition Analysis 2017-2018 (US$)
Table 15: Stents MarketValue Chain Analysis 2017-2018 (US$)
Table 16: Stents MarketPricing Analysis 2018-2023 (US$)
Table 17: Stents MarketOpportunities Analysis 2018-2023 (US$)
Table 18: Stents MarketProduct Life Cycle Analysis 2018-2023 (US$)
Table 19: Stents MarketSupplier Analysis 2017-2018 (US$)
Table 20: Stents MarketDistributor Analysis 2017-2018 (US$)
Table 21: Stents MarketTrend Analysis 2017-2018 (US$)
Table 22: Stents MarketSize 2017 (US$)
Table 23: Stents MarketForecast Analysis 2018-2023 (US$)
Table 24: Stents MarketSales Forecast Analysis 2018-2023 (Units)
Table 25: Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 26: Stents MarketBy Product, Revenue & Volume, By Coronary, 2018-2023 ($)
Table 27: Stents MarketBy Product, Revenue & Volume, By Peripheral, 2018-2023 ($)
Table 28: Stents MarketBy Product, Revenue & Volume, By Stent-Related Implants, 2018-2023 ($)
Table 29: Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 30: Stents MarketBy Application, Revenue & Volume, By Application 1, 2018-2023 ($)
Table 31: Stents MarketBy Application, Revenue & Volume, By Application 2, 2018-2023 ($)
Table 32: Stents MarketBy Application, Revenue & Volume, By Application 3, 2018-2023 ($)
Table 33: Stents MarketBy Application, Revenue & Volume, By Application 4, 2018-2023 ($)
Table 34: Stents MarketBy Application, Revenue & Volume, By Application 5, 2018-2023 ($)
Table 35: North America Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 36: North America Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 37: South america Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 38: South america Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 39: Europe Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 40: Europe Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 41: APAC Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 42: APAC Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 43: Middle East & Africa Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 44: Middle East & Africa Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 45: Russia Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 46: Russia Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 47: Israel Stents Market, Revenue & Volume, By Product, 2018-2023 ($)
Table 48: Israel Stents Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 49: Top Companies 2017 (US$)Stents Market, Revenue & Volume
Table 50: Product Launch 2017-2018Stents Market, Revenue & Volume
Table 51: Mergers & Acquistions 2017-2018Stents Market, Revenue & Volume


List of Figures

Figure 1: Overview of Stents Market2017-2023
Figure 2: Market Share Analysis for Stents Market2017 (US$)
Figure 3: Product Comparison in Stents Market2017-2018 (US$)
Figure 4: End User Profile for Stents Market2017-2018 (US$)
Figure 5: Patent Application and Grant in Stents Market2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Stents Market2017-2018 (US$)
Figure 7: Market Entry Strategy in Stents Market2017-2018
Figure 8: Ecosystem Analysis in Stents Market2017
Figure 9: Average Selling Price in Stents Market2017-2023
Figure 10: Top Opportunites in Stents Market2017-2018
Figure 11: Market Life Cycle Analysis in Stents MarketMarket Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy Product Stents MarketRevenue, 2018-2023 ($)
Figure 13: GlobalBy Application Stents MarketRevenue, 2018-2023 ($)
Figure 14: Global Stents Market- By Geography
Figure 15: Global Stents MarketValue & Volume, By Geography, 2018-2023 ($) 
Figure 16: Global Stents MarketCAGR, By Geography, 2018-2023 (%)
Figure 17: North America Stents MarketValue & Volume, 2018-2023 ($)
Figure 18: US Stents MarketValue & Volume, 2018-2023 ($)
Figure 19: US GDP and Population, 2017-2018 ($)
Figure 20: US GDP – Composition of 2017, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2017-2018 ($)
Figure 22: Canada Stents MarketValue & Volume, 2018-2023 ($)
Figure 23: Canada GDP and Population, 2017-2018 ($)
Figure 24: Canada GDP – Composition of 2017, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 26: Mexico Stents MarketValue & Volume, 2018-2023 ($)
Figure 27: Mexico GDP and Population, 2017-2018 ($)
Figure 28: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 30: South America Stents MarketSouth America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil Stents MarketValue & Volume, 2018-2023 ($)
Figure 32: Brazil GDP and Population, 2017-2018 ($)
Figure 33: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 35: Venezuela Stents MarketValue & Volume, 2018-2023 ($)
Figure 36: Venezuela GDP and Population, 2017-2018 ($)
Figure 37: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 39: Argentina Stents MarketValue & Volume, 2018-2023 ($)
Figure 40: Argentina GDP and Population, 2017-2018 ($)
Figure 41: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 43: Ecuador Stents MarketValue & Volume, 2018-2023 ($)
Figure 44: Ecuador GDP and Population, 2017-2018 ($)
Figure 45: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 47: Peru Stents MarketValue & Volume, 2018-2023 ($)
Figure 48: Peru GDP and Population, 2017-2018 ($)
Figure 49: Peru GDP – Composition of 2017, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 51: Colombia Stents MarketValue & Volume, 2018-2023 ($)
Figure 52: Colombia GDP and Population, 2017-2018 ($)
Figure 53: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 55: Costa Rica Stents MarketCosta Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 56: Costa Rica GDP and Population, 2017-2018 ($)
Figure 57: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 59: Europe Stents MarketValue & Volume, 2018-2023 ($)
Figure 60: U.K Stents MarketValue & Volume, 2018-2023 ($)
Figure 61: U.K GDP and Population, 2017-2018 ($)
Figure 62: U.K GDP – Composition of 2017, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 64: Germany Stents MarketValue & Volume, 2018-2023 ($)
Figure 65: Germany GDP and Population, 2017-2018 ($)
Figure 66: Germany GDP – Composition of 2017, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 68: Italy Stents MarketValue & Volume, 2018-2023 ($)
Figure 69: Italy GDP and Population, 2017-2018 ($)
Figure 70: Italy GDP – Composition of 2017, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 72: France Stents MarketValue & Volume, 2018-2023 ($)
Figure 73: France GDP and Population, 2017-2018 ($)
Figure 74: France GDP – Composition of 2017, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2017-2018 ($)
Figure 76: Netherlands Stents MarketValue & Volume, 2018-2023 ($)
Figure 77: Netherlands GDP and Population, 2017-2018 ($)
Figure 78: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 80: Belgium Stents MarketValue & Volume, 2018-2023 ($)
Figure 81: Belgium GDP and Population, 2017-2018 ($)
Figure 82: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 84: Spain Stents MarketValue & Volume, 2018-2023 ($)
Figure 85: Spain GDP and Population, 2017-2018 ($)
Figure 86: Spain GDP – Composition of 2017, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 88: Denmark Stents MarketValue & Volume, 2018-2023 ($)
Figure 89: Denmark GDP and Population, 2017-2018 ($)
Figure 90: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 92: APAC Stents MarketValue & Volume, 2018-2023 ($)
Figure 93: China Stents MarketValue & Volume, 2018-2023
Figure 94: China GDP and Population, 2017-2018 ($)
Figure 95: China GDP – Composition of 2017, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2017-2018 ($)Stents MarketChina Export and Import Value & Volume, 2017-2018 ($)
Figure 97: Australia Stents MarketValue & Volume, 2018-2023 ($)
Figure 98: Australia GDP and Population, 2017-2018 ($)
Figure 99: Australia GDP – Composition of 2017, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 101: South Korea Stents MarketValue & Volume, 2018-2023 ($)
Figure 102: South Korea GDP and Population, 2017-2018 ($)
Figure 103: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 105: India Stents MarketValue & Volume, 2018-2023 ($)
Figure 106: India GDP and Population, 2017-2018 ($)
Figure 107: India GDP – Composition of 2017, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2017-2018 ($)
Figure 109: Taiwan Stents MarketTaiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 110: Taiwan GDP and Population, 2017-2018 ($)
Figure 111: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 113: Malaysia Stents MarketMalaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 114: Malaysia GDP and Population, 2017-2018 ($)
Figure 115: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 117: Hong Kong Stents MarketHong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 118: Hong Kong GDP and Population, 2017-2018 ($)
Figure 119: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 121: Middle East & Africa Stents MarketMiddle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia Stents MarketRussia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123: Russia GDP and Population, 2017-2018 ($)
Figure 124: Russia GDP – Composition of 2017, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 126: Israel Stents MarketValue & Volume, 2018-2023 ($)
Figure 127: Israel GDP and Population, 2017-2018 ($)
Figure 128: Israel GDP – Composition of 2017, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 130: Entropy Share, By Strategies, 2017-2018* (%)Stents Market
Figure 131: Developments, 2017-2018*Stents Market
Figure 132: Company 1 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 133: Company 1 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 134: Company 1 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 135: Company 2 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 136: Company 2 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 2 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 138: Company 3 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 139: Company 3 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 3 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 141: Company 4 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 142: Company 4 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 4 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 144: Company 5 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 145: Company 5 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 5 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 147: Company 6 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 148: Company 6 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 6 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 150: Company 7 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 151: Company 7 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 7 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 153: Company 8 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 154: Company 8 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 8 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 156: Company 9 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 157: Company 9 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 9 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 159: Company 10 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 160: Company 10 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 10 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 162: Company 11 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 163: Company 11 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 11 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 165: Company 12 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 166: Company 12 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 12 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 168: Company 13 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 169: Company 13 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 13 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 171: Company 14 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 172: Company 14 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 14 Stents MarketNet Sales Share, By Geography, 2017 (%)
Figure 174: Company 15 Stents MarketNet Revenue, By Years, 2017-2018* ($)
Figure 175: Company 15 Stents MarketNet Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 15 Stents MarketNet Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll